Patent · US Active

Formulations of viloxazine

US9662338B2 · kind B2 · utility

3Cited by
7References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2016
Grant dateMay 30, 2017
Priority date—
Expiry dateJun 3, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.